• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Catalog Number 03R89-62
Device Problem Computer Software Problem (1112)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/08/2023
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
On (b)(6) 2023, the customer provided a sample id (b)(6) that was said to have incorrect data populated in the aliniq ams base software regarding a alinity i total b-hcg test result.The following data was provided: 1st result was primary = 964.20 miu/ml; secondary result transmitted from instrument = positive 2nd result after running the automatic dilution, primary result < 7000 miu/ml; secondary result transmitted from instrument = positive however, ams read primary result < 7000 and flag <, for which exists a rule that generates the result as absent.It was noted that the aliniq ams base software was incorrectly configured for the alinity i total b-hcg result.It was noted that the dilution was automatically triggered by the ams due to an incorrect rule configuration.There was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A review of ticket trending did not identify any related trends for the current complaint issue.A review of the device history record did not identify any non-conformances or deviations related to the complaint issue.Labeling was reviewed and adequately addresses the issue under review.In this case, the issue was identified as an incorrect configuration of the qpl (quality programming language) rules on the aliniq ams software version 3.01 (ln 03r89-62) for the alinity i total b-hcg assay.Based on the investigation, the aliniq ams software version 3.01 (ln 03r89-62) is performing as intended, no systemic issue or product deficiency was identified.
 
Event Description
On 08dec2023, the customer provided a sample id (b)(6) that was said to have incorrect data populated in the aliniq ams base software regarding a alinity i total b-hcg test result.The following data was provided: 1st result was primary = 964.20 miu/ml; secondary result transmitted from instrument = positive.2nd result after running the automatic dilution, primary result < 7000 miu/ml; secondary result transmitted from instrument = positive.However, ams read primary result < 7000 and flag <, for which exists a rule that generates the result as absent.It was noted that the aliniq ams base software was incorrectly configured for the alinity i total b-hcg result.It was noted that the dilution was automatically triggered by the ams due to an incorrect rule configuration.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINIQ AMS
Type of Device
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT  00144
Manufacturer (Section G)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT   00144
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18363824
MDR Text Key331308815
Report Number3004032053-2023-00029
Device Sequence Number1
Product Code JQP
UDI-Device Identifier00380740200169
UDI-Public00380740200169
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03R89-62
Device Lot NumberOCN03337
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-